Knowledge Services

Everything you need to know about Federal policies impacting your work.

Analysis

Real-time “what-it-means-to-you” analysis of key Federal policies impacting your goals

Insight

Forward-looking insight into the policy trajectory for your priority issues

Breakdowns

In-depth, actionable breakdowns of all relevant regulations and guidance

Summaries

Concise summaries of impactful policy-driving events, including congressional hearings, agency forums, and MedPAC and MACPAC sessions

Tracking

Detailed briefs of major health care bills, with assessments of their probability of passage and tracking of relevant legislation

Monitoring

Monitoring of all relevant Federal grant, advisory board nomination, and demonstration opportunities

Briefs

Our proprietary Issue Brief series, breaking down the status of the hottest topics in health

Newsletter

A Weekly newsletter framing the upcoming week and recapping recent developments of interest

Policy Hub

Unlimited subscriptions to Policy Hub, our searchable knowledge database and daily e-digest

RECENT ANALYSIS

Committee Approves FY 2026 Funding Bill for USDA, FDA, and Rural Development Along Party Lines

The House Committee on Appropriations convened a markup of the Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Bill for fiscal year (FY) 2026 (text; summary; report language). A summary of key nutrition, rural development, and FDA provisions is included at the end of our full markup summary. The bill was favorably forwarded to the House with a vote of 35-27. What… (McClurg, June 25, 2025) #Budget, #Food and Drug Administration, #Nutrition, #Rural Health

CRS Outlines Legislative Paths for AI Regulation as Congress Considers A 10-Year Moratorium on State AI Laws

The Congressional Research Service issued a report presenting Congress with a broad overview of regulatory options and policy considerations for artificial intelligence (AI). The report outlines how U.S. federal efforts have so far focused on agency-specific oversight, voluntary industry commitments, and the exploration of whether new authorities are needed. CRS contrasts the U.S. approach with international models, noting that while… (Colocho, June 24, 2025) #Budget, #Costs, #Health Information Technology

Award Terms Updated to Require Health Centers to Provide Insulin and EpiPens at or Below 340B Pricing

Pursuant to President Trump’s Executive Order Lowering Drug Prices by Putting Americans First, today, the Health Resources and Services Administration (HRSA) announced that it has updated its award terms to require HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by the center through the 340B Drug Pricing Program. Whereas during President… (Slifer, June 24, 2025) #340B, #Community Health Centers, #Prescription Drugs